Disclosure of interest: Kseniia Manysheva: nothing to disclose E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.04 - STROKE COMPLICATIONS P2565 - ESOC25-2282 ASSESSING THE QUALITY OF VTE PROPHYLACTIC DEVICE USAGE FOR STROKE PATIENTS AT LEEDS GENERAL INFIRMARY: AN AUDIT AND RE-AUDIT Rohid Zamani 1,2 , Daniel McWilliams 1 , Sameer Limaye 1 1 Leeds General Infirmary, Leeds Teaching Hospitals National Health Service Trust, Leeds, United Kingdom, 2 George Eliot Hospital, Nuneaton, United Kingdom Background and Aims: Intermittent pneumatic compression devices (IPCs) and geko devices are used to reduce the risk of VTE in patients who have suffered an acute stroke
And GLP-1 peptide drugs like semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) have undergone extensive testing in clinical trials to become FDA-approved drugs for obesity and type 2 diabetes
The size of the tip on each varies a little bit with the size of the syringe, and we are working and getting a better image available
Until recently, neuroscientists believed that the central nervous system, including the brain, was incapable of neurogenesis and unable to regenerate
Add bacteriostatic water slowly to the lyophilised peptide vial using a syringe